[1]
Karimi-Jafari, M.; Padrela, L.; Walker, G. M.; Croker, D. M. Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications. Cryst. Growth Des. 2018, 18 (10), 6370–6387.
DOI: 10.1021/acs.cgd.8b00933
Google Scholar
[2]
Charoenchaitrakool, M.; Roubroum, T.; Sudsakorn, K. Processing of a Novel Mefenamic Acid−paracetamol−nicotinamide Cocrystal Using Gas Anti-Solvent Process. J. CO2 Util. 2022, 62, 102080.
DOI: 10.1016/j.jcou.2022.102080
Google Scholar
[3]
Bhowmik, A.; Bamane, S.; Saxena, A. K.; Mishra, M. K. Caffeine vs. Theophylline Cocrystals: Insights into Structure–Mechanical Behavior and Piezoelectricity. Cryst. Growth Des. 2025, 25 (13), 5007–5021.
DOI: 10.1021/acs.cgd.5c00491
Google Scholar
[4]
Rodrigues, M.; Baptista, B.; Lopes, J. A.; Sarraguça, M. C. Pharmaceutical Cocrystallization Techniques. Advances and Challenges. Int. J. Pharm. 2018, 547 (1–2), 404–420.
DOI: 10.1016/j.ijpharm.2018.06.024
Google Scholar
[5]
Ngilirabanga, J. B.; Samsodien, H. Pharmaceutical Co‐crystal: An Alternative Strategy for Enhanced Physicochemical Properties and Drug Synergy. Nano Sel. 2021, 2 (3), 512–526.
DOI: 10.1002/nano.202000201
Google Scholar
[6]
Al-Dulaimi, A.; Al-kotaji, M.; Abachi, F. Paracetamol/ Naproxen Co-Crystals; a Simple Way for Improvement of Flowability, Tableting and Dissolution Properties. Iraqi J. Pharm. 2021, 18 (1), 1–19.
DOI: 10.33899/iphr.2021.168798
Google Scholar
[7]
Schenck, L.; Erdemir, D.; Saunders Gorka, L.; Merritt, J. M.; Marziano, I.; Ho, R.; Lee, M.; Bullard, J.; Boukerche, M.; Ferguson, S.; Florence, A. J.; Khan, S. A.; Sun, C. C. Recent Advances in Co-Processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies. Mol. Pharm. 2020, 17 (7), 2232–2244.
DOI: 10.1021/acs.molpharmaceut.0c00198
Google Scholar
[8]
Latif, S.; Abbas, N.; Hussain, A.; Arshad, M. S.; Bukhari, N. I.; Afzal, H.; Riffat, S.; Ahmad, Z. Development of Paracetamol-Caffeine Co-Crystals to Improve Compressional, Formulation and in Vivo Performance. Drug Dev. Ind. Pharm. 2018, 44 (7), 1099–1108.
DOI: 10.1080/03639045.2018.1435687
Google Scholar
[9]
Liu, Y.; Gabriele, B.; Davey, R. J.; Cruz-Cabeza, A. J. Concerning Elusive Crystal Forms: The Case of Paracetamol. J. Am. Chem. Soc. 2020, 142 (14), 6682–6689.
DOI: 10.1021/jacs.0c00321
Google Scholar
[10]
Keshavarz, L.; Pishnamazi, M.; Rao Khandavilli, U. B.; Shirazian, S.; Collins, M. N.; Walker, G. M.; Frawley, P. J. Tailoring Crystal Size Distributions for Product Performance, Compaction of Paracetamol. Arab. J. Chem. 2021, 14 (4), 103089.
DOI: 10.1016/j.arabjc.2021.103089
Google Scholar
[11]
Du, W.; Yang, J.; Peng, Q.; Liang, X.; Mao, H. Comparison Study of Zinc Nanoparticles and Zinc Sulphate on Wheat Growth: From Toxicity and Zinc Biofortification. Chemosphere 2019, 227, 109–116.
DOI: 10.1016/j.chemosphere.2019.03.168
Google Scholar
[12]
Polekkad, A.; Franklin, M. E. E.; Pushpadass, H. A.; Battula, S. N.; Rao, S. B. N.; Pal, D. T. Microencapsulation of Zinc by Spray-Drying: Characterisation and Fortification. Powder Technol. 2021, 381, 1–16.
DOI: 10.1016/j.powtec.2020.12.009
Google Scholar
[13]
Ramesh, V. Third Order Non Linear Material of Zinc Sulphate Doped L-Threonine Dihydrogen Phosphate Single Crystal. Mater. Today Proc. 2020, 33, 4177–4179.
DOI: 10.1016/j.matpr.2020.07.060
Google Scholar
[14]
Zapata, F.; López-Fernández, A.; Ortega-Ojeda, F.; Quintanilla, G.; García-Ruiz, C.; Montalvo, G. Introducing ATR-FTIR Spectroscopy through Analysis of Acetaminophen Drugs: Practical Lessons for Interdisciplinary and Progressive Learning for Undergraduate Students. J. Chem. Educ. 2021, 98 (8), 2675–2686.
DOI: 10.1021/acs.jchemed.0c01231
Google Scholar
[15]
Budziak-Wieczorek, I.; Maciołek, U. Synthesis and Characterization of a (−)-Epicatechin and Barbituric Acid Cocrystal: Single-Crystal X-Ray Diffraction and Vibrational Spectroscopic Studies. ACS Omega 2021, 6 (12), 8199–8209.
DOI: 10.1021/acsomega.0c06239
Google Scholar